6 results match your criteria: "California Keck School of Medicine of USC[Affiliation]"

Objectives: We aimed to evaluate the effect of technical aspects of fetal aortic valvuloplasty (FAV) on procedural risks and pregnancy outcomes.

Background: FAV is performed in cases of severe mid-gestation aortic stenosis with the goal of preventing hypoplastic left heart syndrome (HLHS).

Methods: The International Fetal Cardiac Intervention Registry was queried for fetuses who underwent FAV from 2002 to 2018, excluding one high-volume center.

View Article and Find Full Text PDF

Objective: To evaluate clinical and MRI outcomes after stopping or switching disease-modifying therapy in patients with stable MS.

Methods: A retrospective chart review was conducted of stable MS patients who discontinued or switched their DMT from 2011 to 2015. Clinical and MRI outcomes were obtained at baseline and 1-year follow-up.

View Article and Find Full Text PDF

Phenotype of 7q11.23 duplication: A family clinical series.

Am J Med Genet A

January 2017

Department of Pediatrics, USC University Center for Excellence in Developmental Disabilities, University of Southern California Keck School of Medicine of USC, Children's Hospital Los Angeles, Los Angeles, California.

Duplication 7q11.23 syndrome is the reciprocal of Williams-Beuren deletion syndrome. Studies have reported a recognizable phenotype, including autism, intellectual disability, speech, and language delay, social anxiety, and behavioral difficulties in these individuals.

View Article and Find Full Text PDF

A previously healthy 7-year-old male presented with hypertensive emergency, hypokalemia, and elevated plasma renin activity and aldosterone levels. There was no evidence of virilization or cushingoid features. MRI of the abdomen revealed a large (5 × 5 × 3 cm) peripherally enhancing, heterogeneous mass arising from the left adrenal gland.

View Article and Find Full Text PDF

Objective: To evaluate changes in absolute lymphocyte counts, lymphocyte subsets, and infections in patients treated with dimethyl fumarate (DMF) in comparison to the baseline pre-DMF levels.

Methods: A retrospective chart review was conducted of 23 MS patients treated with DMF. Absolute lymphocyte counts and lymphocyte subsets were obtained at baseline and after at least 3 months of DMF treatment.

View Article and Find Full Text PDF